Sana Biotechnology, Inc.
SANA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001770121
No open-market purchases or sales by Sana Biotechnology, Inc. insiders were filed in the last 90 days; 211 institutions reported holding it in 13F filings for Q2 2026, worth $644.7M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Sana Biotechnology, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 116 | 1 | 125 | +10 |
| Shares | 125.6M | 240 | 128.3M | +2.72M (+2.2%) |
| Value | $807.5M | $2.00K | $769.7M | −$37.8M (−4.7%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Sana Biotechnology, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 735,250 | $4.41M | 2.91% |
| BNP Paribas Arbitrage, SA | 225,732 | $1.35M | 0.00% |
| Teachers Retirement System of the State of Kentucky | 133,061 | $799.0K | 0.01% |
| ExodusPoint Capital Management, LP | 108,639 | $652.0K | 0.01% |
| Trexquant Investment LP | 95,550 | $573.0K | 0.02% |
| HRT Financial LP | 67,970 | $407.0K | 0.00% |
| Boulder Hill Capital Management LP | 51,500 | $309.0K | 0.23% |
| Occudo Quantitative Strategies LP | 48,411 | $290.0K | 0.02% |
| Marshall Wace, LLP | 29,180 | $175.0K | 0.00% |
| Quantamental Technologies LLC | 11,585 | $70.0K | 0.03% |
| American Century Companies Inc | 10,731 | $64.0K | 0.00% |
| Bridgefront Capital, LLC | 10,475 | $63.0K | 0.06% |
| Point72 Hong Kong Ltd | 9,733 | $58.0K | 0.00% |
| Amundi | 7,881 | $49.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 1,781 | $11.0K | 0.00% |
| Global Trust Asset Management, LLC | 298 | $2.00K | 0.00% |
| Lindbrook Capital, LLC | 234 | $1.00K | 0.00% |
Sold out (7)
Institutions that held Sana Biotechnology, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Prescott General Partners LLC | 122,097 | $785.0K |
| SG Americas Securities, LLC | 118,044 | $759.0K |
| Fred Alger Management, LLC | 57,506 | $370.0K |
| Victory Capital Management Inc | 12,524 | $81.0K |
| HSBC Holdings PLC | 11,047 | $71.0K |
| Group One Trading, L.P. | 1,600 | $10.0K |
| Venture Visionary Partners LLC | 100 | $643 |
Not filed for Q3 2022 yet (1)
Institutions that held Sana Biotechnology, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Private Capital Group, LLC | 240 | $2.00K |